{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:03:31Z","timestamp":1762459411787,"version":"build-2065373602"},"reference-count":147,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.drudis.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T03:19:57Z","timestamp":1472786397000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies"],"prefix":"10.1016","volume":"22","author":[{"given":"Wei-Xin","family":"Chin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swee Kim","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin Jang Hann","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2016.08.008_bib0740","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.drudis.2016.08.008_bib0745","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bbagrm.2011.05.014","article-title":"miRNA cassettes in viral vectors: problems and solutions","volume":"1809","author":"Liu","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2016.08.008_bib0750","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.micro.60.080805.142205","article-title":"Virus counterdefense: diverse strategies for evading the RNA-silencing immunity","volume":"60","author":"Li","year":"2006","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0755","article-title":"Plant virus silencing suppressors and RNA silencing in plants","author":"Zhang","year":"2001","journal-title":"eLS"},{"key":"10.1016\/j.drudis.2016.08.008_bib0760","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib0765","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chom.2013.09.002","article-title":"Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells","volume":"14","author":"Seo","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2016.08.008_bib0770","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/jir.2014.0003","article-title":"Processing of double-stranded RNA in mammalian cells: a direct antiviral role?","volume":"34","author":"Gantier","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib0775","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1128\/JVI.02655-12","article-title":"Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome","volume":"87","author":"Zheng","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0780","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12869","article-title":"RNA viruses can hijack vertebrate microRNAs to suppress innate immunity","volume":"506","author":"Trobaugh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib0785","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1128\/JVI.00985-14","article-title":"Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs","volume":"88","author":"Bogerd","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0790","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1073\/pnas.1213515110","article-title":"Competing and noncompeting activities of miR-122 and the 5\u2032 exonuclease Xrn1 in regulation of hepatitis C virus replication","volume":"110","author":"Li","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib0795","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib0800","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib0805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2014\/718743","article-title":"Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter","volume":"2014","author":"Mowa","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.drudis.2016.08.008_bib0810","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1093\/nar\/gkt068","article-title":"The anti-genomic (negative) strand of hepatitis C virus is not targetable by shRNA","volume":"41","author":"Lisowski","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib0815","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1128\/JVI.05298-11","article-title":"Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence","volume":"85","author":"Stein","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0820","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/mt.2012.119","article-title":"Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model","volume":"20","author":"Suhy","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib0825","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2174\/09298673113209990118","article-title":"RNAi in clinical studies","volume":"20","author":"Kubowicz","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2016.08.008_bib0830","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/v2071448","article-title":"siRNA for influenza therapy","volume":"2","author":"Barik","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2016.08.008_bib0835","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature14442","article-title":"Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib0840","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/AAC.00014-09","article-title":"RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy","volume":"53","author":"Alvarez","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.08.008_bib0845","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/rccm.201003-0422OC","article-title":"RNA interference therapy in lung transplant patients infected with respiratory syncytial virus","volume":"183","author":"Zamora","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drudis.2016.08.008_bib0850","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.09.050","article-title":"5\u2032-Triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells","volume":"721","author":"Chen","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0855","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2011.05.001","article-title":"Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice","volume":"141","author":"Ebert","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2016.08.008_bib0860","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/JVI.79.2.1027-1035.2005","article-title":"Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches","volume":"79","author":"Gitlin","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0865","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/JVI.79.11.7050-7058.2005","article-title":"Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region","volume":"79","author":"Wilson","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-10-214","article-title":"Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B","volume":"10","author":"Li","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.drudis.2016.08.008_bib0875","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2015.04.042","article-title":"Inhibition of replication of hepatitis B virus in transgenic mice following administration of hepatotropic lipoplexes containing guanidinopropyl-modified siRNAs","volume":"209","author":"Marimani","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2016.08.008_bib0880","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/mt.2013.31","article-title":"Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection","volume":"21","author":"Wooddell","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib0885","doi-asserted-by":"crossref","first-page":"e17889","DOI":"10.1371\/journal.pone.0017889","article-title":"Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis","volume":"6","author":"Ye","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2016.08.008_bib0890","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00705-013-1738-z","article-title":"Evaluation of single and dual siRNAs targeting rabies virus glycoprotein and nucleoprotein genes for inhibition of virus multiplication in vitro","volume":"158","author":"Meshram","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0895","first-page":"5","article-title":"RNAi-based treatment for rabies: current achievements and insights towards a cure","volume":"2","author":"Brand\u00e3o","year":"2015","journal-title":"Br. J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0900","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/jcs.066399","article-title":"Breaking down the barriers: siRNA delivery and endosome escape","volume":"123","author":"Dominska","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drudis.2016.08.008_bib0905","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/ph6020223","article-title":"RNAi therapeutic platforms for lung diseases","volume":"6","author":"Fujita","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2016.08.008_bib0910","series-title":"RNA Interference","first-page":"163","article-title":"Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes","author":"Sebesty\u00e9n","year":"2015"},{"key":"10.1016\/j.drudis.2016.08.008_bib0915","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.antiviral.2007.11.009","article-title":"Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)","volume":"77","author":"DeVincenzo","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib0920","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2007.06.015","article-title":"Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome","volume":"47","author":"Watanabe","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib0930","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/gt.2014.94","article-title":"Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses","volume":"22","author":"Ivacik","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib0935","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12033-013-9685-1","article-title":"Protection of mice against lethal rabies virus challenge using short interfering RNAs (siRNAs) delivered through lentiviral vector","volume":"56","author":"Singh","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.drudis.2016.08.008_bib0940","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.drudis.2016.08.008_bib0945","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/mt.2008.144","article-title":"Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic","volume":"16","author":"Giering","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib0950","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1292\/jvms.13-0127","article-title":"Adeno-associated viruses serotype 2-mediated RNA interference efficiently inhibits rabies virus replication in vitro and in vivo","volume":"75","author":"Wu","year":"2013","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.drudis.2016.08.008_bib0955","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib0960","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/mt.2008.245","article-title":"Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9","volume":"17","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-015-0174-y","article-title":"RNA interference approaches for treatment of HIV-1 infection","volume":"7","author":"Bobbin","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.drudis.2016.08.008_bib0970","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.3390\/v5112898","article-title":"Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practice","volume":"5","author":"DiGiusto","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2016.08.008_bib0975","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral vectors for gene therapy: translational and clinical outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.drudis.2016.08.008_bib0980","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4137\/EBO.S11412","article-title":"Antiviral stratagems against HIV-1 using RNA interference (RNAi) technology","volume":"9","author":"Vlachakis","year":"2013","journal-title":"Evol. Bioinform."},{"key":"10.1016\/j.drudis.2016.08.008_bib0985","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.antiviral.2011.03.174","article-title":"Species specific inhibition of viral replication using dicer substrate siRNAs (DsiRNAs) targeting the viral nucleoprotein of the fish pathogenic rhabdovirus viral hemorrhagic septicemia virus (VHSV)","volume":"90","author":"Bohle","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib0990","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jfd.12227","article-title":"Inhibition of spring viraemia of carp virus replication in an Epithelioma papulosum cyprini cell line by RNAi","volume":"38","author":"Gotesman","year":"2015","journal-title":"J. Fish Dis."},{"key":"10.1016\/j.drudis.2016.08.008_bib0995","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00705-010-0882-y","article-title":"Inhibition of viral hemorrhagic septicemia virus replication using a short hairpin RNA targeting the G gene","volume":"156","author":"Kim","year":"2010","journal-title":"Arch. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1000","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.antiviral.2009.02.202","article-title":"Inhibition of porcine reproductive and respiratory syndrome virus replication by adenovirus-mediated RNA interference both in porcine alveolar macrophages and swine","volume":"82","author":"Li","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-015-0277-5","article-title":"Synergistic inhibition of avian leukosis virus subgroup J replication by miRNA-embedded siRNA interference of double-target","volume":"12","author":"Wei","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.drudis.2016.08.008_bib1010","doi-asserted-by":"crossref","first-page":"e21552","DOI":"10.1371\/journal.pone.0021552","article-title":"Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1","volume":"6","author":"Stewart","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2016.08.008_bib1015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jbiotec.2013.11.022","article-title":"RNAi-based inhibition of porcine reproductive and respiratory syndrome virus replication in transgenic pigs","volume":"171","author":"Li","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1020","doi-asserted-by":"crossref","first-page":"e06951","DOI":"10.7554\/eLife.06951","article-title":"Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection","volume":"4","author":"Hu","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.drudis.2016.08.008_bib1025","doi-asserted-by":"crossref","first-page":"e64613","DOI":"10.1371\/journal.pone.0064613","article-title":"Production of cloned pigs with targeted attenuation of gene expression","volume":"8","author":"Bordignon","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.drudis.2016.08.008_bib1030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/187152612800100099","article-title":"The burgeoning burden of respiratory syncytial virus among children","volume":"12","author":"Hall","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.drudis.2016.08.008_bib1035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1218-z","article-title":"Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom","volume":"15","author":"Fleming","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drudis.2016.08.008_bib1040","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1517\/13543784.2015.1099626","article-title":"Novel therapies and vaccines against the human respiratory syncytial virus","volume":"24","author":"Rivera","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2016.08.008_bib1045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12194","article-title":"Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients","volume":"16","author":"Marcelin","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.08.008_bib1050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2015.08.012","article-title":"ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients","volume":"35","author":"Gottlieb","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.drudis.2016.08.008_bib1055","doi-asserted-by":"crossref","first-page":"e57525","DOI":"10.1371\/journal.pone.0057525","article-title":"Changes in innate and permissive immune responses after HBV transgenic mouse vaccination and long-term-siRNA treatment","volume":"8","author":"Ren","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.drudis.2016.08.008_bib1060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2016.08.008_bib1065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12013-014-9847-1","article-title":"Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice","volume":"69","author":"Li","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.drudis.2016.08.008_bib1070","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1038\/srep15259","article-title":"Combinatorial RNA interference therapy prevents selection of pre-existing HBV variants in human liver chimeric mice","volume":"5","author":"Shih","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2016.08.008_bib1075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.26339","article-title":"Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance","volume":"58","author":"Lan","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2016.08.008_bib1080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12013-014-9846-2","article-title":"siRNA combinations mediate greater suppression of hepatitis B virus replication in mice","volume":"69","author":"Li","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.drudis.2016.08.008_bib1085","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/hepr.12189","article-title":"Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand","volume":"44","author":"Huang","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1090","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.bmc.2013.04.073","article-title":"Inhibition of hepatitis B virus replication in cultured cells and in vivo using 2\u2032-O-guanidinopropyl modified siRNAs","volume":"21","author":"Marimani","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.08.008_bib1095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3851\/IMP1798","article-title":"RNA interference and its potential applications to chronic HBV treatment: results of a Phase I safety and tolerability study","volume":"16","author":"Gish","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1100","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.3390\/ijms160817589","article-title":"Progress and prospects of anti-HBV gene therapy development","volume":"16","author":"Maepa","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drudis.2016.08.008_bib1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2015.06.019","article-title":"Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent","volume":"121","author":"Gish","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2016.08.008_bib1115","first-page":"3","article-title":"Shifting epidemiology of flaviviridae","volume":"12","author":"Petersen","year":"2005","journal-title":"J. Travel Med."},{"issue":"Suppl. 12","key":"10.1016\/j.drudis.2016.08.008_bib1120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib1130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.08.008_bib1135","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/v3091739","article-title":"Functional RNA elements in the dengue virus genome","volume":"3","author":"Gebhard","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2016.08.008_bib1140","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1371\/journal.pmed.0030096","article-title":"A single siRNA suppresses fatal encephalitis induced by two different flaviviruses","volume":"3","author":"Kumar","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.drudis.2016.08.008_bib1145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pharmtox-010715-103633","article-title":"RNA interference (RNAi)-based therapeutics: delivering on the promise?","volume":"56","author":"Bobbin","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP2851","article-title":"Antiviral therapy for human rabies","volume":"20","author":"Appolinario","year":"2014","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.rvsc.2011.06.008","article-title":"Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice","volume":"93","author":"Sonwane","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.drudis.2016.08.008_bib1160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virusres.2011.08.004","article-title":"Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge","volume":"163","author":"Gupta","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virusres.2012.07.024","article-title":"Small interfering RNAs targeting the rabies virus nucleoprotein gene","volume":"169","author":"Yang","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1590\/S1517-83822013005000050","article-title":"In vitro and in vivo inhibition of rabies virus replication by RNA interference","volume":"44","author":"Ono","year":"2013","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1175","doi-asserted-by":"crossref","DOI":"10.4172\/2572-0406.1000e101","article-title":"Towards structural based drug development for ebola virus disease","author":"Zhao","year":"2016","journal-title":"J. Chem. Biol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2015.12.005","article-title":"Progression of ebola therapeutics during the 2014\u20132015 outbreak","volume":"22","author":"Mendoza","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.drudis.2016.08.008_bib1185","doi-asserted-by":"crossref","first-page":"e46396","DOI":"10.1371\/journal.pone.0046396","article-title":"Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication","volume":"7","author":"Lam","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2016.08.008_bib1190","doi-asserted-by":"crossref","first-page":"e2405","DOI":"10.1371\/journal.pntd.0002405","article-title":"Administration of E2 and NS1 siRNAs inhibit Chikungunya virus replication in vitro and protects mice infected with the virus","volume":"7","author":"Parashar","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2016.08.008_bib1195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.antiviral.2013.03.010","article-title":"Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes","volume":"98","author":"Zhou","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1200","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/ijc.26197","article-title":"The synergistic therapeutic effect of cisplatin with human papillomavirus E6\/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo","volume":"130","author":"Jung","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drudis.2016.08.008_bib1205","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1215","series-title":"Molecular Epidemiology of Microorganisms: Methods and Protocols","first-page":"105","article-title":"Clustered regularly interspaced short palindromic repeats (CRISPRs) for the genotyping of bacterial pathogens","author":"Grissa","year":"2009"},{"key":"10.1016\/j.drudis.2016.08.008_bib1220","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks216","article-title":"Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli","author":"Yosef","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1225","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1101\/gad.1742908","article-title":"Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes","volume":"22","author":"Carte","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.drudis.2016.08.008_bib1230","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1192272","article-title":"Sequence- and structure-specific RNA processing by a CRISPR endonuclease","volume":"329","author":"Haurwitz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1235","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.1159689","article-title":"Small CRISPR RNAs guide antiviral defense in prokaryotes","volume":"321","author":"Brouns","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1240","doi-asserted-by":"crossref","first-page":"10092","DOI":"10.1073\/pnas.1102716108","article-title":"RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions","volume":"108","author":"Wiedenheft","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib1245","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2012.03.020","article-title":"Mechanism of foreign DNA selection in a bacterial adaptive immune system","volume":"46","author":"Sashital","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2016.08.008_bib1250","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro3569","article-title":"An updated evolutionary classification of CRISPR-Cas systems","volume":"13","author":"Makarova","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature12048","article-title":"A CRISPR\/Cas system mediates bacterial innate immune evasion and virulence","volume":"497","author":"Sampson","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib1260","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molcel.2014.09.027","article-title":"Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus","volume":"56","author":"Tamulaitis","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2016.08.008_bib1265","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.molcel.2014.10.005","article-title":"RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus","volume":"56","author":"Staals","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2016.08.008_bib1270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature13769","article-title":"Programmable RNA recognition and cleavage by CRISPR\/Cas9","volume":"516","author":"O\u2019Connell","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib1275","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.1422340112","article-title":"Cas9-mediated targeting of viral RNA in eukaryotic cells","volume":"112","author":"Price","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib1280","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1128\/JVI.01795-05","article-title":"Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins","volume":"80","author":"Mino","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2010.20","article-title":"Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs","volume":"18","author":"Cradick","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1290","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/mt.2010.302","article-title":"Meganuclease-mediated inhibition of HSV1 infection in cultured cells","volume":"19","author":"Grosse","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1295","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/mt.2013.170","article-title":"Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases","volume":"21","author":"Bloom","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1300","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1305","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1310","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib1315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.antiviral.2015.10.004","article-title":"Targeting hepatitis B virus cccDNA using CRISPR\/Cas9","volume":"123","author":"Kennedy","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1320","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/mt.2016.94","article-title":"Complete spectrum of CRISPR\/Cas9-induced mutations on HBV cccDNA","volume":"24","author":"Seeger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1325","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.drudis.2016.08.008_bib1330","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476","author":"Kennedy","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.drudis.2016.08.008_bib1335","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2016.08.008_bib1340","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1345","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.3748\/wjg.v21.i32.9554","article-title":"Dual gRNAs guided CRISPR\/Cas9 system inhibits hepatitis B virus replication","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1350","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of hepatitis B virus by the CRISPR\/Cas9 system via targeting the conserved regions of the viral genome","volume":"96","author":"Liu","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1355","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/srep13734","article-title":"CRISPR\/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X","volume":"5","author":"Karimova","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2016.08.008_bib1360","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1365","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.drudis.2016.08.008_bib1370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virusres.2016.04.003","article-title":"CRISPR\/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse","volume":"217","author":"Zhu","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.drudis.2016.08.008_bib1375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.stem.2014.04.020","article-title":"Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing","volume":"15","author":"Veres","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drudis.2016.08.008_bib1380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stem.2014.06.011","article-title":"Whole-genome sequencing analysis reveals high specificity of CRISPR\/Cas9 and TALEN-based genome editing in human iPSCs","volume":"15","author":"Smith","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drudis.2016.08.008_bib1385","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1390","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.08.008_bib1395","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1400","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2016.08.008_bib1405","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib1410","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","volume":"6","author":"Liao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2016.08.008_bib1415","doi-asserted-by":"crossref","first-page":"e115987","DOI":"10.1371\/journal.pone.0115987","article-title":"CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection","volume":"9","author":"Wang","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.drudis.2016.08.008_bib1420","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/gt.2016.41","article-title":"Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study","volume":"23","author":"Kaminski","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2016.08.008_bib1425","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1430","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.08.008_bib1435","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1440","doi-asserted-by":"crossref","first-page":"612823","DOI":"10.1155\/2014\/612823","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells","volume":"2014","author":"Hu","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.drudis.2016.08.008_bib1445","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2016.08.008_bib1450","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","article-title":"RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.08.008_bib1455","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1099\/jgv.0.000012","article-title":"CRISPR\/Cas9-mediated genome editing of Epstein\u2013Barr virus in human cells","volume":"96","author":"Yuen","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drudis.2016.08.008_bib1460","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10529-015-2020-0","article-title":"Inhibiting cyprinid herpesvirus-3 replication with CRISPR\/Cas9","volume":"38","author":"Zhao","year":"2016","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.drudis.2016.08.008_bib1465","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1038\/srep19176","article-title":"A CRISPR\/Cas9 and Cre\/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2016.08.008_bib1470","doi-asserted-by":"crossref","first-page":"e0136046","DOI":"10.1371\/journal.pone.0136046","article-title":"CRISPR\/Cas9 system as an agent for eliminating polyomavirus JC infection","volume":"10","author":"Wollebo","year":"2015","journal-title":"PLOS ONE"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616302951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616302951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:28:18Z","timestamp":1761222498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644616302951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1359644616302951"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2016.08.008","relation":{},"ISSN":["1359-6446"],"issn-type":[{"type":"print","value":"1359-6446"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}